Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 03, 2026
ONEOK (OKE) Q2 2026 Earnings: Watching for Volume Momentum After +26% YTD Gains

ONEOK (OKE) Q2 2026 Earnings: Watching for Volume Momentum After +26% YTD Gains

Key Takeaways

  • ONEOK (OKE) reports second-quarter 2026 results after the market closes on Monday, August 3, with a conference call scheduled for August 4 at 11 a.m. Eastern.
  • Consensus estimates point to earnings of approximately $1.39 per share on revenue of roughly $10.8 billion, reflecting a significant year-over-year revenue increase of about 37%.
  • The company enters this report having raised its full-year 2026 guidance in April to an EPS midpoint of $5.53 and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $8.25 billion, despite a Q1 EPS miss.
  • Analyst sentiment remains divided, with a consensus "Hold" rating, seven Buy ratings, and eleven Hold ratings, while the stock has gained over 26% year-to-date.
  • Key metrics under scrutiny include NGL (natural gas liquids) raw feed throughput, Permian and Bakken processing volumes, and fee-based earnings stability across the company's approximately 60,000-mile pipeline network.

Why This Earnings Report Matters

ONEOK's second-quarter report arrives at an important time for the midstream sector and the company's own story. After a Q1 2026 performance that delivered a 12% year-over-year increase in net income to $776 million and a 13% rise in adjusted EBITDA to $2.0 billion, management raised full-year guidance. Yet the stock's upward move has drawn downgrades from Morgan Stanley and Jefferies, both citing concerns about multiyear growth conviction. With shares trading near $90 and a dividend yield approaching 4.8%, investors are weighing whether volume-driven execution can overcome the cautious stance Wall Street has taken heading into the second half of the year.

Earnings Expectations

Analysts project ONEOK will post second-quarter earnings of roughly $1.39 per share, according to the Zacks Consensus Estimate, with revenues expected to reach approximately $10.8 billion — a roughly 37% jump from the year-ago period. Other consensus panels place EPS estimates in a slightly higher $1.40 to $1.41 range on revenue closer to $8.95 billion. Earnings estimates for the quarter have trended modestly lower over the past 60 days, with a decline of approximately 3.5%.

Mizuho recently raised its Q2 adjusted EBITDA estimate for ONEOK to $2.05 billion, citing stronger Permian Basin processing volumes and Bakken activity that held up better than typical seasonal patterns would suggest. UBS similarly expects second-quarter EBITDA to climb to roughly $2.06 billion, with seasonal strength across most business units partially offset by softer natural gas pipeline results. Wells Fargo identified ONEOK as one of the names likely to exceed consensus this quarter, pointing to wide Katy-Waha marketing spreads during the period.

Investors will focus intently on volume metrics: NGL raw feed throughput, which surged 15% in Q1; refined products volumes shipped, which rose 12%; and natural gas volumes processed, up 5%. The company's 90% fee-based earnings model provides cash flow visibility, but growth hinges on sustained throughput momentum across its gathering, processing, fractionation, and transportation segments. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Reaction and Investor Sentiment

Sentiment heading into ONEOK's second-quarter print reflects a tug-of-war between strong operational momentum and persistent valuation skepticism. The stock has rallied more than 21% year-to-date, outpacing the S&P 500's roughly 9% gain, yet the analyst community remains broadly cautious. Of 23 analysts covering the stock, 7 rate it a Buy or equivalent, 11 maintain a Hold, and one recent downgrade landed at Sell. The average 12-month price target sits near $92 to $96, implying modest upside of 3% to 6% from current levels.

Several recent downgrades have shaped the cautious tone. Morgan Stanley cut ONEOK to Equal Weight, acknowledging value but flagging weak investor conviction around multiyear EBITDA growth. Jefferies moved to Hold from Buy, citing fading confidence in a meaningful Bakken growth acceleration. On the bullish side, UBS maintains a Buy rating with a $108 target, pointing to AI-linked power demand, export terminal interest, and disciplined capital spending as underappreciated catalysts.

Forward Outlook and Key Factors to Monitor

Looking beyond the second-quarter print, investors should monitor several interconnected themes that will shape ONEOK's trajectory through the remainder of 2026 and into 2027.

First, volume sustainability is paramount. The Q1 surge in NGL raw feed throughput, refined products shipments, and natural gas processing volumes set a high bar. If management confirms these trends held through the second quarter and provides upbeat commentary about ongoing demand, it would reinforce the thesis that ONEOK benefits from network-wide utilization rather than temporary tailwinds. Conversely, any softening in Bakken or Mid-Continent activity would validate the more cautious analyst stance.

Second, the natural gas liquids export story continues to gain attention. UBS highlighted ONEOK's planned Texas City export terminal and noted strong customer interest in capacity. Additionally, discussions with large technology companies about gas supply for AI-related power projects — including facilities with approximately 5 gigawatts of capacity — represent a longer-term demand catalyst that could reshape growth expectations beyond the current fiscal year.

Third, capital allocation discipline remains a differentiating factor. ONEOK kept 2026 capital expenditure guidance unchanged at $2.7 billion to $3.2 billion while raising earnings guidance, suggesting improved returns on existing assets rather than growth funded by aggressive spending. The relocation of a 150 million cubic feet per day processing plant to the Permian Basin from North Texas exemplifies this optimization mindset.

Finally, investors should watch the trajectory of Katy-Waha natural gas price differentials. These spreads provided a tailwind during the second quarter but have already begun narrowing as new takeaway capacity enters service, potentially reducing a source of earnings upside in the second half of the year. From what I see, this is important because it could affect near-term results even if longer-term demand holds up.

Using Tickeron AI Tools in My Research

When preparing for earnings like this one, I often turn to Tickeron’s AI Screener to quickly filter comparable midstream names and review recent technical and fundamental signals. It helps me cross-check volume trends and peer performance in a structured way without spending hours on manual screens. This kind of tool has become a regular part of how I organize ideas ahead of reports.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: OKE

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


OKE's RSI Indicator ascending out of oversold territory

The RSI Indicator for OKE moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In 16 of the 19 cases the stock moved higher. This puts the odds of a move higher at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 58 cases where OKE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.

Following a +1.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where OKE advanced for three days, in 251 of 378 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

OKE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OKE as a result. In 61 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.

The Moving Average Convergence Divergence Histogram (MACD) for OKE turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 25 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 53%.

OKE moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OKE crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OKE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

The Aroon Indicator for OKE entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.435) is normal, around the industry mean (179.095). P/E Ratio (15.306) is within average values for comparable stocks, (22.536). Projected Growth (PEG Ratio) (1.674) is also within normal values, averaging (13.660). Dividend Yield (0.048) settles around the average of (0.050) among similar stocks. P/S Ratio (1.487) is also within normal values, averaging (4.657).

The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 41, placing this stock slightly worse than average.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. OKE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Enterprise Products Partners LP (NYSE:EPD), Energy Transfer LP (NYSE:ET), Kinder Morgan (NYSE:KMI), Targa Resources Corp (NYSE:TRGP), Cheniere Energy (NYSE:LNG), Plains All American Pipeline LP (NASDAQ:PAA), Antero Midstream Corp (NYSE:AM), CMB.TECH NV (NYSE:CMBT), Plains GP Holdings LP (NASDAQ:PAGP), Scorpio Tankers (NYSE:STNG).

Industry description

Oil & Gas Pipelines industry includes companies that transport natural gas and crude oil through pipelines. These companies also collect and market the fuels. The pipeline segment could be considered as a midstream operation – functioning as a link between the upstream and downstream operations in the oil and gas industry. Some of the largest U.S. pipeline players include Enterprise Products Partners L.P, TC Energy Corporation and Energy Transfer, L.P.

Market Cap

The average market capitalization across the Oil & Gas Pipelines Industry is 16.25B. The market cap for tickers in the group ranges from 32.88K to 104.83B. ENB holds the highest valuation in this group at 104.83B. The lowest valued company is BROGF at 32.88K.

High and low price notable news

The average weekly price growth across all stocks in the Oil & Gas Pipelines Industry was 2%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 9%. PXS experienced the highest price growth at 21%, while TOPS experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Oil & Gas Pipelines Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was -53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 25
P/E Growth Rating: 54
Price Growth Rating: 52
SMR Rating: 53
Profit Risk Rating: 41
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
OKE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which purchases, gathers, compresses, transports and stores natural gas

Industry OilGasPipelines

Industry
Oil And Gas Pipelines
Address
100 West Fifth Street
Phone
+1 918 588-7000
Employees
6326
Web
https://www.oneok.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
Toyota Motor Corporation (TM) stands as the world's largest automaker by volume, designing, manufacturing, and selling a wide range of vehicles—from sedans and trucks to SUVs and electrified models like hybrids—under brands including Toyota, Lexus, and Daihatsu. The company's business model centers on a robust global supply chain, vertical integration in components like engines and transmissions, and a multi-pathway approach that prioritizes hybrids alongside EVs and hydrogen technology. In the highly competitive automotive sector, Toyota maintains a strong position, particularly with its dominant hybrid market share, though it faces mounting pressure from EV frontrunners such as BYD in China and Tesla worldwide. From what I see, these core strengths explain much of the recent stock action: the resilience from hybrids offers some stability, but the slower EV rollout and heavy China exposure heighten sales volatility in a shifting market.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Sable Offshore Corp. (SOC) shares fell 7.40% in the most recent completed session, closing at $16.52 versus a prior close of $17.84. The pullback followed a volatile stretch in which SOC traded between $15.76 and $19.21 over just two sessions, reflecting profit‑taking after a strong run in March.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.